Market Access/ News/ News EU okays BMS’ azacitidine pill for first-line maintenance of AML Phil Taylor acute myeloid leukaemia, Bristol-Myers Squibb, ema, EU, Oncology, Onureg 0 Comment Bristol-Myers Squibb has been granted EU approval for Onureg (azacitidine), a tablet form of an intravenous drug that Share X EU okays BMS’ azacitidine pill for first-line maintenance of AML https://pharmaphorum.com/news/eu-okays-bms-azacitidine-pill-for-first-line-maintenance-of-aml/